In contrast, aberrant CD56 expression might not affect the clinical behavior and outcome of pcALCLs according to several sporadic case reports, which behaved largely in an indolent way similar to other pcALCLs and much better than other CD56+ lymphomas involving the skin [7, 10, 14–17]. Here, NCAM1 is linked to lymphoma.